Literature DB >> 17576947

The current status of evaluation and treatment of high-risk cutaneous melanoma: therapeutic breakthroughs remain elusive.

Matthew H Kanzler.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17576947     DOI: 10.1001/archderm.143.6.785

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  4 in total

Review 1.  Importance of tumor load in the sentinel node in melanoma: clinical dilemmas.

Authors:  Alexander C J van Akkooi; Cornelis Verhoef; Alexander M M Eggermont
Journal:  Nat Rev Clin Oncol       Date:  2010-06-22       Impact factor: 66.675

Review 2.  Sentinel lymph node biopsy in Japan.

Authors:  Hisashi Uhara; Minoru Takata; Toshiaki Saida
Journal:  Int J Clin Oncol       Date:  2009-12-05       Impact factor: 3.402

Review 3.  Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.

Authors:  Nikolas K Haass; Keiran S M Smalley
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

4.  Letter to the editor.

Authors:  Ricardo E Achenbach
Journal:  Dermatol Pract Concept       Date:  2011-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.